Drostazone 100 - Alphazone Pharmaceuticals

First released in the 1970s under the name Drolban, drostanolone propionate was approved for use in female cancer patients, particularly for hormone-sensitive breast tumors. As a DHT derivative, it offered strong anti-estrogenic action with fewer androgenic side effects. Its medical relevance declined over time, but the compound found new life in physique sports, where it was used to achieve a dry, defined muscular look. It continues to circulate in underground labs today.

Disclaimer: Information provided it this page is for general information only and does not substitute for professional medical advice.

For detailed information about Drostazone 100 by Alphazone Pharmaceuticals, consult with your doctor or healthcare professional.